Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/1999
05/12/1999CN1216470A DHEA combination therapy
05/12/1999CN1216468A Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
05/11/1999US5902588 Water soluble nonantigenic polymer with a secondary or tertiary amine, spacer moiety and covalent linkage to a nucleophile consisting of proteins and chemotherapeutic agents; improved bioactivity, pi and ph optimum
05/11/1999US5902586 Meningococcal polysaccharide conjugate vaccine
05/11/1999US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists
05/11/1999US5902583 Genetic induction of receptors for targeted radiotherapy
05/11/1999US5902576 Antitumor pharmaceutical composition comprising IL-6 transfected cells
05/11/1999US5902565 Vaccine comprising immunogen adsorbed to an aluminum salt adjuvant, said vaccine preparation being a free flowing powder
05/11/1999CA2141871C Novel attenuated pseudomonas aeruginosa strains
05/11/1999CA1340538C Recombinant coccidiosis vaccines
05/11/1999CA1340537C Polymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them
05/11/1999CA1340534C Production of immunoproximity catalysts
05/06/1999WO1999022007A1 Cbfaie10: a human skd1 gene
05/06/1999WO1999022000A1 Inhibitor protein of the wnt signal pathway
05/06/1999WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
05/06/1999WO1999021989A1 Human cofactor-a gene cbfblg07
05/06/1999WO1999021988A1 THE HUMAN VESICLE TRAFFICKING PROTEIN SEC22b GENE OF CBFBBA01
05/06/1999WO1999021969A1 Serum-free, low-protein media for rotavirus vaccine production
05/06/1999WO1999021959A2 Helicobacter pylori vaccine formulations
05/06/1999WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR
05/06/1999WO1999021882A1 Hbv binding polypeptide
05/06/1999WO1999021591A1 Compositions and methods for delivery of genetic material
05/06/1999WO1999021582A2 Application of tnf antagonists as medicaments for treating septic diseases
05/06/1999WO1999021581A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
05/06/1999WO1999021579A1 Solid dispersing vaccine composition for oral delivery
05/06/1999WO1999021552A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
05/06/1999WO1999012963A3 Cysteine rich receptors: trail
05/06/1999WO1999009164A9 Coding sequence haplotypes of the human brca2 gene
05/06/1999WO1999009156A3 Protease-related protein
05/06/1999EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB)
05/06/1999EP0913480A2 Chorismate synthase
05/06/1999EP0913479A2 Adenine glycosylase
05/06/1999EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993
05/06/1999EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase
05/06/1999EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof
05/06/1999EP0913474A2 Dbpa, a helicase from Staphylococcus aureus
05/06/1999EP0913472A2 Human LIG-1 Homolog (HLIG-1)
05/06/1999EP0913471A2 Cdna clone HNEAA81 that encodes a human 7-transmembrane receptor
05/06/1999EP0913157A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method
05/06/1999EP0912747A1 Aspartic protease
05/06/1999EP0912743A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
05/06/1999EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/06/1999EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
05/06/1999EP0912724A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
05/06/1999EP0912721A1 Vaccine preparations
05/06/1999EP0912611A1 Human monoclonal antibodies to the hepatitis b surface antigen
05/06/1999EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines
05/06/1999EP0912607A2 Vaccines comprising synthetic genes
05/06/1999EP0912205A2 Method of preparing a composite bone graft
05/06/1999EP0912198A1 Immunoliposomes that optimize internalization into target cells
05/06/1999EP0912195A1 Vaccine comprising antigens bound to carriers through labile bonds
05/06/1999EP0912194A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
05/06/1999EP0912193A1 Vaccine to prevent streptococcal endocarditis
05/06/1999EP0912192A1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors
05/06/1999EP0742721B1 Methods of prolonged suppression of humoral immunity
05/06/1999EP0713388B1 A method for high loading of vesicles with biopolymeric substances
05/06/1999EP0680333B1 Prevention and treatment of cytomegalovirus using aminopeptidase
05/06/1999EP0589004B1 Process for the determination of peptides corresponding to immunologically important epitopes of hcv
05/06/1999EP0576439B1 Monoclonal antibody against lps core
05/06/1999EP0541692B1 Herpes simplex virus vp16 vaccines
05/06/1999CA2306790A1 Application of tnf antagonists as medicaments for treating septic diseases
05/06/1999CA2306733A1 Compositions and methods for delivery of genetic material
05/06/1999CA2306564A1 Serum-free, low-protein media for rotavirus vaccine production
05/06/1999CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
05/06/1999CA2252999A1 Novel rncs
05/05/1999CN1216064A Synthetic HIV genes
05/05/1999CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
05/05/1999CN1215991A Enteric-coated pharmaceutical compositions of mycophenolate
05/05/1999CN1215751A Analgesic health-care soap
05/05/1999CN1215729A Clostridium perfringens vaccine
05/04/1999US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents
05/04/1999US5900240 Antidiabetic mixture
05/04/1999US5900238 Vaccine delivery system
05/04/1999CA2180424C Drugs, vaccines and hormones in polylactide coated microspheres
05/04/1999CA2129637C Treatment for inflammatory bowel disease
05/04/1999CA1340530C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
05/04/1999CA1340526C Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
05/04/1999CA1340525C Immunoassay for the detection of a-haloacetamides
05/04/1999CA1340521C Hepatitis b virus antigen and a process for producing the same
05/04/1999CA1340520C Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
05/03/1999CA2249002A1 Aroc
04/1999
04/30/1999CA2249056A1 Lacc
04/30/1999CA2248996A1 Novel ornithine carbamoyltransferase
04/29/1999WO1999020774A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
04/29/1999WO1999020766A2 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
04/29/1999WO1999020764A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance
04/29/1999WO1999020759A1 Chemokines with amino-terminal modifications
04/29/1999WO1999020756A2 Human toll homologues
04/29/1999WO1999020755A2 Novel cytokine receptors
04/29/1999WO1999020739A2 Novel lactic acid bacteria species
04/29/1999WO1999020656A1 Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
04/29/1999WO1999020650A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
04/29/1999WO1999020307A1 NOVEL pheS (BETA)
04/29/1999WO1999020306A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
04/29/1999WO1999020305A1 Veterinary vaccines
04/29/1999WO1999020304A1 Passive immunization against clostridium difficile disease
04/29/1999WO1999020303A1 Neospora vaccines
04/29/1999WO1999020302A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
04/29/1999WO1999020301A1 Tumour vaccine
04/29/1999WO1999020297A1 Prevention and treatment of adhesion formation
1 ... 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 ... 1823